Eslicarbapezine acetate

N/A

Report date: 2022/06/30 14:39:32

Base Information

Drug NameEslicarbapezine acetate
Drug Alias NameCLX-104CLX-CNS-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockersSodium channels blockers
TargetsVoltage-gated T-type calcium channelSodium channels
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellix Bio Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCellix Bio Pvt Ltd
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A